Acne vulgaris is an extremely common dermatological problem among young Pakistani patients and this group of patients with asian skin types represent a particular clinical challenge for dermatologists treating acne. In many cases, this is due to the higher risk of postinflammatory hyperpigmentation in patients with asian skin types. Very few studies of any of the major acne therapies have been carried out in this population. A study was conducted to assess the efficacy and safety of topical azelaic acid 20% cream as a treatment for acne vulgaris in Pakistani patients. An open-label study of azelaic acid 20% cream in 65 Pakistani patients, aged 12-30 years, for 12 weeks was carried out. All patients had mild to moderate facial acne as defined by the Leeds scoring system, they were instructed to apply the medication twice daily. Lesion counts and severity scores were assessed at 4, 8 and 12 weeks. A total of 44 patients completed the study. Azelaic acid 20% cream showed clear efficacy against both inflammatory and non-inflammatory lesions. In two-thirds of cases patients experienced reductions in both number of hyperpigmented macules and density of hyperpigmentation. It was concluded that azelaic acid 20% cream is an effective, well-tolerated topical therapy for acne patients and it is able to reduce both inflammatory and non-inflammatory lesions, as well as prevent and alleviate acne-associated hyperpigmentation.